Navigation Links
Leading Biotechnology Company Awards Phase III Cardiac Safety Study to iCardiac
Date:9/24/2009

iCardiac continues #1 market position in automated QT studies

Rochester, NY (PRWEB) September 24, 2009 -- iCardiac Technologies, Inc., a leader in advanced cardiac core lab services and QT analysis, announced today that a leading biotechnology company has awarded iCardiac a multi-center international Phase III cardiac safety study. iCardiac will provide end-to-end study management, site logistics and scientific reporting, as well as advanced ECG analytics. The study will utilize iCardiac's Highly Automated QT(sm) to dramatically improve study precision.

"We are pleased that the industry continues the rapid adoption of iCardiac's automated QT methods, which have demonstrated superiority to traditional manual or semi-automated ECG evaluation," said Sasha Latypova, Executive Vice President. "With this contract award, iCardiac continues its clear scientific and market leadership for automated QT studies with a larger number of studies completed or contracted than other commercial ECG core laboratories."

In October 2005, the FDA introduced a new guidance for industry (ICH E14) requiring the evaluation of pro-arrhythmic potential of new drugs by measuring the QT segment of ECGs collected in clinical trials. The dissatisfaction among pharmaceutical developers with the poor precision, high rate of false positives/negatives and high cost of the "gold standard" manual or semi-automated QT measurements has lead to efforts toward providing more advanced cardiac safety analytics.

About iCardiac Technologies
iCardiac Technologies, Inc. is a technologically-differentiated cardiac core lab providing the industry's most sophisticated FDA-accepted cardiac safety assessment methodologies for Phase I through Phase IV studies, supported by expert scientific consultation, end-to-end project management, worldwide site and equipment logistics, 24/7 customer su
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
3. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
4. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
7. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium
10. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
11. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... AVIV, Israel , July 23, 2014 /PRNewswire/ ... ., a portfolio company of Trendlines Agtech ... one of Israel,s leading ... http://photos.prnewswire.com/prnh/20140121/666259-a) , Valentis,s technology combines nanocrystalline ... plant pulp waste, with additional nanoparticles to produce ...
(Date:7/23/2014)... , July 23, 2014 regulated information ... research and development pipeline with positive topline results ... brivaracetam . This study was designed to evaluate the ... and 200 mg/day, without titration) compared to placebo, ... with partial-onset seizures, not fully controlled despite treatment ...
(Date:7/23/2014)... PARK, Calif. , July 23, 2014  Sofinnova ... investment firm, today announced the closing of Sofinnova Venture ... million and in excess of the initial fund target ... helping entrepreneurs build successful biotechnology companies. Consistent with recent ... with promising later stage clinical programs, along with select ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
... Radi Medical Systems Sponsors Case Review with Drs. Morton Kern, Nico ... ... Oct. 19 The use,of fractional flow reserve (FFR) for optimizing ... Cardiovascular,Therapeutics symposium, TCT 2007, which will take place Oct. 20-25 in,Washington. ...
... /Xinhua-PRNewswire-FirstCall/ -- Simcere,Pharmaceutical Group (NYSE: SCR ), ... in the rapidly growing Chinese marketplace,announced today that ... results,on Monday, November 5, 2007, before the market ... Jinsheng Ren, and chief financial,officer, Frank Zhigang Zhao, ...
... BSX ) today announced financial results for the third,quarter ended ... per share (EPS) for the fourth quarter of 2007. Highlights ... at the mid-point of guidance, and adjusted ... one position in the worldwide drug-eluting stent (DES) ...
Cached Biology Technology:Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 4Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 5Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 6Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 7Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 8Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 9Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 10Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 11Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 12Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 13Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 14Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 15Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 16Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 17Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 18Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 19Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 20Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 21Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 22Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 23Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 24Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 25
(Date:7/23/2014)... WOODS HOLE, MA -- What do mollusks, starfish, ... shared marine habitat, they are all calcifiersorganisms that ... carbonate skeletons and shells for stability and protection. ... Bulletin , published by the Marine Biological Laboratory, ... ocean composition changes worldwide. , As atmospheric carbon ...
(Date:7/23/2014)... 2014   MedNet Solutions , a global ... management systems, is pleased to announce that ... industry executive with over 25 years of experience, ... will be responsible for MedNet,s day-to-day operating activities, ... quality product/service delivery.  "We welcome ...
(Date:7/23/2014)... . , Animals ... which might be very different from ours. Some bird ... sunlight in the atmosphere to calibrate their orientation systems. ... in Seewiesen, Germany, and Queen,s University Belfast have discovered ... the greater mouse-eared bat, has the capability to orient ...
Breaking Biology News(10 mins):Calcification in changing oceans explored in special issue of The Biological Bulletin 2MedNet Appoints Clareece West As Chief Operating Officer 2Bats use the evening sky's polarization pattern for orientation 2
... NEW YORK (Feb. 29, 2008) -- Teens who can ... ads are less likely to succumb to alcohol advertising ... a three-year study of inner-city middle school students by ... journal Addictive Behaviors (April print edition). Previous research has ...
... derives from the red jungle fowl, but new research from ... chicken are more complicated than that. The ... legs and found to their surprise that this genetic heredity ... The study is being published today in the Web ...
... discovered how roots find their way past obstacles to grow ... Science, also explains how germinating seedlings penetrate the soil without ... in the fuzzy coat of hairs on the roots of ... control mechanism that enables these hairs to find their way ...
Cached Biology News:Learning how to say 'no' to alcohol advertising and peer pressure works for inner-city adolescents 2Darwin was wrong about the wild origin of the chicken 2
... The Sciclone ALH 4000 workstation is the ... seeking to introduce automated liquid handling capabilities,into ... that need to support routine applications on ... and,integrated for walk-away automation even when ...
Cells are grown in triple flasks, roller bottles, or NUNC Factory. Viability and growth curves are generated from a parallel representative culture....
NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....
... Life Sciences provides cost effective cell culture ... or monoclonal antibodies. Quality at a reasonable ... you require research or commercial product, we ... methods such as roller bottles, hollow fiber, ...
Biology Products: